PharmiWeb.com - Global Pharma News & Resources
07-Jan-2019

Global Traumatic Brain Injury Therapeutics Market (2019-2023) with Baxter, Fresenius, Johnson & Johnson Services, Novartis and Pfizer Dominating - ResearchAndMarkets.com

The "Global Traumatic Brain Injury Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The traumatic brain injury therapeutics market growth will stand at a CAGR of close to 5% during the forecast period

The high prevalence of TBI globally is because of the increase in the number of falls, road accidents, and other causes. In most of these cases people with TBI need to be hospitalized. The prevalence of TBI among various age groups and eternal causes are important driving factors for the global TBI therapeutics market.

Array of new drug approvals

The drug development process is a long and expansive process. The number of molecules under development for the treatment of TBI is increasing at a substantial rate because of the rising prevalence of TBI globally.

Preference for substitutes

Most drugs are mostly symptomatic and not curative. The substitutes prove to be more efficient and are preferred among patients. This is expected to pose a challenge to the market.

Key Players

  • Baxter
  • Fresenius
  • Johnson & Johnson Services
  • Novartis
  • Pfizer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Anticonvulsants - Market size and forecast 2018-2023
  • Anti-anxiety agents - Market size and forecast 2018-2023
  • Anticoagulants - Market size and forecast 2018-2023
  • Analgesics - Market size and forecast 2018-2023
  • Other therapeutics - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Baxter
  • Fresenius
  • Johnson & Johnson Services
  • Novartis
  • Pfizer

For more information about this report visit https://www.researchandmarkets.com/research/k34dvs/global_traumatic?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190107005550/en/

Editor Details

Last Updated: 07-Jan-2019